Leung, Y., Vad, N., Ye, A., Santos, D., Cao, W., Czupalla, C., Vivian, J., Williams, C., Sapugay, J., Harbell, M., Lippow, S., Carroll, C., Kates, L., Haugen, B., Bolton, G., Armanini, M., Aydin, I., Whidden, M., Velasco-Delgado, M., Chu, F., Wechsler, E., Nguyen, N., Robinson, W., Serafini, T., Emerling, D., Greenberg, N., Manning-Bog, A., & Scholz, A. (n.d.). 689 ATRC-101 Drives Potent Single-Agent Activity in Mouse Syngeneic Tumor Models via a Novel Cellular Mechanism of Action. Journal for immunotherapy of cancer, 8, A413–A414. http://access.bl.uk/ark:/81055/vdc_100144719175.0x00000d